Previous 10 | Next 10 |
WALTHAM, Mass., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced it will present five posters, including results from a real-world study on patient experience, at the American Society for Bone and Mineral Research (ASBMR) 2019 Annual Meeting, which...
WALTHAM, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS) today announced its participation in the following conferences in September 2019. Radius Health management will host meetings with investors at the Citi 14 th Annual Biotech Conference in Boston on Se...
The following slide deck was published by Radius Health, Inc. in conjunction with their 2019 Q2 earnings Read more ...
Radius Health, Inc. (RDUS) Q2 2019 Earnings Conference Call August 7, 2019 09:00 ET Company Participants Elhan Webb - Head, IR & External Communications Jesper Høiland - President, CEO & Director Joseph Kelly - SVP, Sales & Marketing Charles Morris - Chief Medi...
Radius Health (NASDAQ: RDUS ): Q2 Non-GAAP EPS of -$0.55 beats by $0.21 ; GAAP EPS of -$0.77 beats by $0.10 . Revenue of $41M (+81.2% Y/Y) beats by $0.4M . Press Release More news on: Radius Health, Inc., Earnings news and commentary, Healthcare stocks news,
TYMLOS® U.S. net sales were $41.0 million in the second quarter of 201 9, an 81% growth over the second quarter of 2018. TYMLOS continued increasing its share of the U.S. anabolic osteoporosis market capturing an average of 35% total market share and 46% share in new patients ...
AAOI , AGO , AIG , ALB , AMPH , ANGI , ARNA , ASRT , ATO , AVLR , AZPN , BKNG , BREW , CABO , CAI , CCMP , CDE , CECO , CLI , COLL , CPA , CPRX , CSGS , CTL , CVNA , CWH , DAR , DOX , DVAX , EB , ECPG , ENS , ENV , ET , EVRG , FG , FLO , FNV , FOSL , ...
Radius Health ( RDUS +6.2% ) is up, albeit on below-average volume, on the heels of the launch of a Phase 3 clinical trial, wearABLe, evaluating its abaloparatide transdermal patch for the potential treatment of postmenopausal women with osteoporosis at high risk for fracture. More new...
Abaloparatide-Patch patient assessment study results demonstrated high patient acceptability and self-administration accuracy over a 29-day period Levels of PINP, a biomarker for bone formation, after one month in patient assessment study were consistent with results in Phase 3 ACTIVE stu...
WALTHAM, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its second quarter 2019 financial results on Wednesday, August 7 th , 2019. The Company will host a conference call and live audio webcast at 4:30 p.m. ET that day to discuss ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 10:10:00 ET July 19, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech, Cleantech Sectors. The newest biotech companies are involved in blood disorder treat...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 54.4% to $0.4264 on volume of 158,036,142 shares Versus Systems Inc. (VS) rose 73.5% to $2.29 on volume of 40,036,424 shares Tesla Inc. (TSLA) rose 5.3% to $220.97 on volume of 32,375,487 shar...
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ: RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. ...